4.8 Article

Global Profiling of Acetyltransferase Feedback Regulation

Journal

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Volume 138, Issue 20, Pages 6388-6391

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jacs.6b03036

Keywords

-

Funding

  1. AbbVie
  2. Bayer Pharma AG
  3. Boehringer Ingelheim
  4. Canada Foundation for Innovation
  5. Eshelman Institute for Innovation
  6. Genome Canada
  7. Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD] [115766]
  8. Janssen
  9. Merck Co.
  10. Novartis Pharma AG
  11. Ontario Ministry of Economic Development and Innovation
  12. Pfizer
  13. Sao Paulo Research Foundation-FAPESP
  14. Takeda
  15. Wellcome Trust
  16. NIH, National Cancer Institute [ZIA BC011488-02]

Ask authors/readers for more resources

Lysine acetyltransferases (KATs) are key mediators of cell signaling. Methods capable of providing new insights into their regulation thus constitute an important goal. Here we report an optimized platform for profiling KAT ligand interactions in complex proteomes using inhibitor-functionalized capture resins. This approach greatly expands the scope of KATs, KAT complexes, and CoA-dependent enzymes accessible to chemoproteomic methods. This enhanced profiling platform is then applied in the most comprehensive analysis to date of KAT inhibition by the feedback metabolite CoA. Our studies reveal that members of the KAT superfamily possess a spectrum of sensitivity to CoA and highlight NAT10 as a novel KAT that may be susceptible to metabolic feedback inhibition. This platform provides a powerful tool to define the potency and selectivity of reversible stimuli, such as small molecules and metabolites, that regulate KAT-dependent signaling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine Acetylation

Jonathan H. Shrimp, Yihang Jing, Supuni Thalalla Gamage, Kathryn M. Nelson, Joseph Han, Keri M. Bryson, David C. Montgomery, Justin M. Thomas, Kellie D. Nance, Sunny Sharma, Stephen D. Fox, Thorkell Andressen, Wilson R. Sinclair, Hong Wu, Abdellah Allali-Hassani, Guillermo Senisterra, Masoud Vedadi, Denis Lafontaine, Jayme L. Dahlin, Ronen Marmorstein, Michael A. Walters, Jordan L. Meier

Summary: Remodelin, a putative small molecule inhibitor of RNA acetyltransferase NAT10, was found to be a cryptic assay interference compound that interacts with multiple protein targets in cells and does not affect the formation of ac4C. Biophysical analyses did not show direct evidence of interaction between remodelin and the NAT10 acetyltransferase active site.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

Article Biochemistry & Molecular Biology

Harnessing Ionic Selectivity in Acetyltransferase Chemoproteomic Probes

Yihang Jing, Jose L. Montano, Michaella Levy, Jeffrey E. Lopez, Pei-Pei Kung, Paul Richardson, Krzysztof Krajewski, Laurence Florens, Michael P. Washburn, Jordan L. Meier

Summary: Chemical proteomics offers a powerful strategy for high-throughput assignment of enzyme function or inhibitor selectivity, but optimizing probes for specific enzyme family members and distinguishing signals from background noise remain challenging. This study introduces a physiochemical discernment strategy based on the CoA cofactor for improving chemical proteomics, demonstrating its efficacy in identifying optimized pulldown probes and comparing its selectivity against traditional competitive methods. The use of CoA-based chemoproteomic probes is validated in evaluating the specificity of small molecule acetyltransferase inhibitors, showcasing their potential in drug discovery.

ACS CHEMICAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Synthesis and Evaluation of a Stable Isostere of Malonyllysine

Yihang Jing, Sarah E. Bergholtz, Anthony Omole, Rhushi A. Kulkarni, Thomas T. Zengeya, Euna Yoo, Jordan L. Meier

Summary: This study presents a new chemical strategy for synthesizing a stable isostere of malonyllysine, which can mimic features of endogenous lysine modification and be used for tool development and functional analysis. The isostere shows resistance to thermal decarboxylation and can be recognized by anti-malonyllysine antibodies and histone deacylases.

CHEMBIOCHEM (2022)

Article Chemistry, Multidisciplinary

Site-Specific Synthesis of N4-Acetylcytidine in RNA Reveals Physiological Duplex Stabilization

David Bartee, Kellie D. Nance, Jordan L. Meier

Summary: This study reports the synthesis and biophysical characterization of ac4C in its endogenous eukaryotic sequence context, establishing a chemical foundation for understanding the function of a universally conserved nucleobase in biology and disease.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Article Biochemistry & Molecular Biology

Protonation-Dependent Sequencing of 5-Formylcytidine in RNA

Courtney N. Link, Supuni Thalalla Gamage, Diamond Gallimore, Robert Kopajtich, Christine Evans, Samantha Nance, Stephen D. Fox, Thorkell Andresson, Raj Chari, Joseph Ivanic, Holger Prokisch, Jordan L. Meier

Summary: Chemical modification of cytidine in noncoding RNAs is important for translation regulation and disease. However, the distribution and dynamics of these modifications are still unknown due to a lack of sensitive sequencing technologies. In this study, a protonation-dependent sequencing reaction is developed to detect 5fC and 5caC in RNA, enhancing the reactivity and sensitive detection of these modified cytidine residues. This method provides a molecular foundation for studying the role of oxidized RNA cytidine residues in diseases.

BIOCHEMISTRY (2022)

Meeting Abstract Biochemistry & Molecular Biology

Defining the role of RNA acetylation via a sequence-specific RNA acetyltransferase

Samantha R-A Nance, Jordan L. Meier, Raj Chari, Christine N. Evans

FASEB JOURNAL (2022)

Article Biochemistry & Molecular Biology

Direct anabolic metabolism of three-carbon propionate to a six-carbon metabolite occurs in vivo across tissues and species

Mary T. Doan, Michael D. Neinast, Erika L. Varner, Kenneth C. Bedi, David Bartee, Helen Jiang, Sophie Trefely, Peining Xu, Jay P. Singh, Cholsoon Jang, J. Eduardo Rame, Donita C. Brady, Jordan L. Meier, Kenneth B. Marguiles, Zoltan Arany, Nathaniel W. Snyder

Summary: Research has shown that mammals can synthesize a six-carbon compound through the metabolism of propionate, and this reaction has been confirmed in humans and mice.

JOURNAL OF LIPID RESEARCH (2022)

Article Biochemistry & Molecular Biology

Probing small ribosomal subunit RNA helix 45 acetylation across eukaryotic evolution

Marie-Line Bortolin-Cavaille, Quillien Aurelie, Thalalla Gamage Supuni, Justin M. Thomas, Aldema Sas-Chen, Sunny Sharma, Celia Plisson-Chastang, Laurence Vandel, Patrick Blader, Denis L. J. Lafontaine, Schraga Schwartz, Jordan L. Meier, Jerome Cavaille

Summary: This study reveals the essential role of SNORD13 in the acetylation of a specific cytidine in human and zebrafish 18S rRNA. However, this acetylation does not have a significant impact on human cell growth, ribosome biogenesis, translation, or development. The study also identifies several novel SNORD13 genes and discovers an atypical SNORD13-like RNA in Drosophila melanogaster.

NUCLEIC ACIDS RESEARCH (2022)

Article Multidisciplinary Sciences

Statin therapy inhibits fatty acid synthase via dynamic protein modifications

Alec G. Trub, Gregory R. Wagner, Kristin A. Anderson, Scott B. Crown, Guo-Fang Zhang, J. Will Thompson, Olga R. Ilkayeva, Robert D. Stevens, Paul A. Grimsrud, Rhushikesh A. Kulkarni, Donald S. Backos, Jordan L. Meier, Matthew D. Hirschey

Summary: Statins, commonly prescribed drugs for the prevention of cardiovascular disease, have pleiotropic effects on cells. By inhibiting HMGCR, statins increase HMG-CoA levels and modify fatty acid synthase (FAS), leading to altered cellular signaling. This study reveals communication between cholesterol and lipid biosynthesis pathways.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

PI3K drives the de novo synthesis of coenzyme A from vitamin B5

Christian C. Dibble, Samuel A. Barritt, Grace E. Perry, Evan C. Lien, Renee C. Geck, Sarah E. DuBois-Coyne, David Bartee, Thomas T. Zengeya, Emily B. Cohen, Min Yuan, Benjamin D. Hopkins, Jordan L. Meier, John G. Clohessy, John M. Asara, Lewis C. Cantley, Alex Toker

Summary: In response to hormones and growth factors, the PI3K signalling network plays a crucial role in regulating metabolism and growth by controlling cellular nutrient uptake, energy generation, cofactor production, and macromolecule biosynthesis. This study reveals that PI3K signalling stimulates the de novo synthesis of coenzyme A (CoA), a key metabolic cofactor, and identifies PANK2 and PANK4 as substrates of the PI3K effector kinase AKT. Furthermore, the study shows that PANK4 acts as a suppressor of CoA synthesis and phosphorylation by AKT relieves this suppression. Ultimately, the PI3K-PANK4 axis regulates important processes such as lipid metabolism and proliferation by controlling the abundance of acetyl-CoA and other acyl-CoAs.

NATURE (2022)

Article Biochemistry & Molecular Biology

Conditional Covalent Lethality Driven by Oncometabolite Accumulation

Minervo Perez, Kellie D. Nance, Daniel W. Bak, Supuni Thalalla Gamage, Susana S. Najera, Amy N. Conte, W. Marston Linehan, Eranthie Weerapana, Jordan L. Meier

Summary: This study found that the electrophilicity of the metabolome in Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) may lead to unique susceptibilities to covalent small molecules, resulting in cytotoxicity. The chemoproteomic target identification method can be used to identify new functional oncometabolite targets.

ACS CHEMICAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Antisense pairing and SNORD13 structure guide RNA cytidine acetylation

Supuni Thalalla Gamage, Marie-Line Bortolin-Cavaille, Courtney Link, Keri Bryson, Aldema Sas-Chen, Schraga Schwartz, Jerome Cavaille, Jordan L. Meier

Summary: There are two methods for studying RNA-guided cytidine acetylation in human cells: rescuing h45 in a SNORD13 knockout cell line by ectopically expressing SNORD13, and defining the structure and sequence elements critical for SNORD13 function by using mutant snoRNAs in combination with nucleotide resolution ac(4)C sequencing. Additionally, the substrate specificity of endogenous NAT10-SNORD13 can be studied through mutational analysis of an ectopically expressed pre-rRNA substrate.
Meeting Abstract Oncology

NAT10 promotes metastasis through enhancer remodeling of cancer cells

Ruhul Amin, Ngoc-Han Ha, Jordan L. Meier, Kent W. Hunter

CANCER RESEARCH (2023)

Article Biochemistry & Molecular Biology

Cytidine acetylation yields a hypoinflammatory synthetic messenger RNA

Kellie D. Nance, Supuni Thalalla Gamage, Md Masud Alam, Acong Yang, Michaella J. Levy, Courtney N. Link, Laurence Florens, Michael P. Washburn, Shuo Gu, Joost J. Oppenheim, Jordan L. Meier

Summary: Synthetic mRNA is a promising therapeutic platform in oncology and infectious disease treatment. The naturally occurring nucleobase N-4-acetylcytidine (ac4C) can reduce inflammatory gene expression in immune cells caused by synthetic mRNA, thereby modulating RNA-protein interactions.

CELL CHEMICAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Target 2035-update on the quest for a probe for every protein

Susanne Mueller, Suzanne Ackloo, Arij Al Chawaf, Bissan Al-Lazikani, Albert Antolin, Jonathan B. Baell, Hartmut Beck, Shaunna Beedie, Ulrich A. K. Betz, Gustavo Arruda Bezerra, Paul E. Brennan, David Brown, Peter J. Brown, Alex N. Bullock, Adrian J. Carter, Apirat Chaikuad, Mathilde Chaineau, Alessio Ciulli, Ian Collins, Jan Dreher, David Drewry, Kristina Edfeldt, Aled M. Edwards, Ursula Egner, Stephen Frye, Stephen M. Fuchs, Matthew D. Hall, Ingo Hartung, Alexander Hillisch, Stephen H. Hitchcock, Evert Homan, Natarajan Kannan, James R. Kiefer, Stefan Knapp, Milka Kostic, Stefan Kubicek, Andrew R. Leach, Sven Lindemann, Brian D. Marsden, Hisanori Matsui, Jordan L. Meier, Daniel Merk, Maurice Michel, Maxwell R. Morgan, Anke Mueller-Fahrnow, Dafydd R. Owen, Benjamin G. Perry, Saul H. Rosenberg, Kumar Singh Saikatendu, Matthieu Schapira, Cora Scholten, Sujata Sharma, Anton Simeonov, Michael Sundstrom, Giulio Superti-Furga, Matthew H. Todd, Claudia Tredup, Masoud Vedadi, Frank von Delft, Timothy M. Willson, Georg E. Winter, Paul Workman, Cheryl H. Arrowsmith

Summary: Twenty years after the first draft of the human genome was published, our understanding of the human proteome is still incomplete. The majority of proteins in the human proteome remain uncharacterized, with only a small percentage successfully targeted for drug discovery. Target 2035 aims to bridge this gap by developing new technologies for the entire human proteome by 2035.

RSC MEDICINAL CHEMISTRY (2022)

No Data Available